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Background: The mite Psoroptes cuniculi is a common worldwide ectoparasite and the most frequently found in
rabbit farms. It causes significant economic losses on commercial rabbit breeding associated with poor leather
quality, reduced conception rates, weight loss, poor growth and death. Several strategies have been proposed for
the treatment of mange caused by this mite, ranging from the use of acaricides, entomopathogenic fungi, essential
oils and vaccines. However, therapy and control of both human scabies and animal mange are still based mainly on
the use of drugs and chemicals such as ivermectin, which involves disadvantages including genotoxic and
cytotoxic effects, resistance and environmental damage. Bacillus thuringiensis is a bacterium, innocuous for human
being, domestic animals and plants that produces highly biodegradable proteins, and has been used worldwide for
biological control. The aim of this work was to find an alternative treatment based on biological control for scabies
caused by Psoroptes cuniculi, using protein extracts from strains of Bacillus thuringiensis.
Methods: P. cuniculi mites were obtained from naturally infected New Zealand rabbits, and different doses of
protein from B. thuringiensis were added to the mites. We measured mortality and obtained the median lethal
concentration and median lethal times. For histological analysis, the mites were fixed in 10 % formalin, processed
according to the paraffin embedded tissue technique. Sections were stained with hematoxylin-eosin to observe
the general histological structure.
Results: We report here for the first time evidence about the in vitro acaricidal effect caused by the strain GP532 of
B. thuringiensis on the mite Psoroptes cuniculi, with an LC50 of 1.3 mg/ml and a LT50 of 68 h. Histological alterations
caused by B. thuringiensis on this mite, included the presence of dilated intercellular spaces in the basal
membrane, membrane detachment of the peritrophic matrix and morphological alterations in columnar cells of
the intestine.
Conclusions: Since this mite is an obligate ectoparasite that affects rabbits, goats, horses, cows and sheep, B.
thuringiensis protein extracts are proposed as a potential treatment for biological control of mange in farm
animals.
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The mite Psoroptes cuniculi (P. cuniculi) is a common
worldwide ectoparasite and the most frequently found in
rabbit farms. This mite causes otitis, the most common
disease in domestic rabbits, and the main reason that
the owners seek veterinarian. Thus, this parasite affects
the general animal health and hygiene [1]. P. cuniculi
infestation can cause considerable weight loss, less favor-
able feed conversion rates, vestibular dysfunction, and
meningitis, frequently complicated by secondary bacter-
ial infections [2]. It causes significant economic losses
associated with poor leather quality, reduced conception
rates, weight loss, poor growth and death [3].
Several strategies have been proposed for the treat-
ment of mange caused by P. cuniculi, ranging from the
use of acaricides, entomopathogenic fungi and essential
oils, to vaccines [4, 5]. However, therapy and control of
both human scabies and animal mange are still based
mainly on the use of drugs and chemicals such as iver-
mectin [6]. The use of drugs, such as ivermectin, to con-
trol this parasite has disadvantages, since it has both,
genotoxic and cytotoxic effects. In addition, their wide-
spread use induces resistance, accompanied by environ-
mental pollution [7–10]. These facts associated with the
interest in the consumption of products ensuring good
sanitary quality, hygiene, and proper handling have lead
research efforts to discover new effective compounds.
Bacillus thuringiensis (B. thuringiensis) is a Gram-positive
bacterium, innocuous for human being, domestic animals
and plants. It produces highly biodegradable proteins, and
has been used worldwide for biological control against
several agriculture pests and some mosquitoes vectors of
human diseases [11, 12], and more recently it has been
proposed to be used against some parasites that affect ani-
mal and human health [13]. Over 90 % of the market for
bio-insecticides include products based on this bacterium
[14], and worldwide there are about 60,000 isolates of B.
thuringiensis in public and private collections, that may
have specific insecticidal activity [15–17]. The aim of this
work was to study the acaricidal potential of protein ex-
tracts of strains of B. thuringiensis, finding that the strain
GP532 had an LC50 of 1.3 mg/ml and acts at short times
(LT50 = 68 h) in in vitro studies. Furthermore, we report
that the acaricidal effect of B. thuringiensis protein ex-




All animal procedures followed the animal care and ex-
perimentation practices recommended as per Mexican
regulations (NOM-062-ZOO-1999). These regulations
are in strict accordance with the recommendations
in the Guide for the Care and Use of LaboratoryAnimals of the National Institutes of Health (NIH
and The Weatherall Report), ensuring compliance
with international regulations and guidelines. The
present manuscript does not contain clinical studies
or patient data.
Isolation of the B. thuringiensis strains
Corpses of P. cuniculi were taken from a sample of a
scab from New Zealand infected rabbit and placed indi-
vidually in a sterile microcentrifuge tube. They were
washed twice with sodium hypochlorite 1 % and with
sterile water. Then they were placed individually in a
sterile microcentrifuge tube, 500 μl of liquid Luria-
Bertani (LB) medium was added to each tube and the
corpses were macerated with sterile tip. The tubes were
incubated at 30 ° C during 72 h. After this, 100 μl of the
culture were diluted with 800 μl of sterile water and sub-
jected to a heat shock of 60° by one hour, to eliminate
fungi or no spore-forming bacteria. A loop was taken,
seeded in a petri dish with solid LB medium and incu-
bated by 24 h, a single colony was taken and seeded on
HCT media. The strains which produced crystals were
selected and kept in LB and glycerol 60 % [11, 18]. The
strains were deposited at the B. thuringiensis collection
of the laboratory of Vegetal Parasitology of the Biological
Research Center (LVP-BRC) at the University of the
State of Morelos, Mexico.
Adult mites
P. cuniculi mites were obtained from five naturally in-
fected New Zealand rabbits tranquilized with intramus-
cular administration of ketamine/xylazine (40 mg/kg and
10 mg/kg). Scabs containing mites were obtained by
scraping from the external ear, placed in the bottom of
50 mL tubes, and kept at 28 ± 2 °C during 15 min, to
stimulate migration of the mites off scabs [19]. Mites
were identified using a stereomicroscope according to
the morphological features of their species [20], and only
adult mites migrating at least to the mark corresponding
to 25 mL of height in the 50 ml tube were included in
the bioassays.
Selection of strains and production of spore-crystal
proteins
Strains of B. thuringiensis were obtained from the strain
collection of the LVP-BRC. We tested 12 strains isolated
from corpses of P. cuniculi, and the GP526 strain iso-
lated from Meloidogyne sp, all of them grown in HCT
medium at 28 ± 2 °C until complete sporulation (72 h).
Total proteins (spores and crystals) were recovered with
a bacteriological loop and suspended in sterile water
containing protease inhibitor PMSF 100 μM. Total
protein concentration was quantified by the Bradford
technique [21].
Fig. 1 Toxicity induced 72 h post incubation of P. cuniculi mites for
60 s with total proteins derived from 13 different strains of B.
thuringiensis. Mean ± SD of the percentage of mortality is shown.
*P ≤ 0.05, **P ≤ 0.01 and ***P≤ 0.001, Kruskal-Wallis test
Table 1 Time-response toxicity induced by strains of B.
thuringiensis on mites incubated for 60 s
Time post-treatment
Strain 24 h 48 h 72 h
Control 6.3 ± 1.73 9.92 ± 2.55 16.46 ± 2.72
GP532 11.41 ± 4.6*** 18.88 ± 7.92*** 34.62 ± 5.96***
GP522 8.51 ± 1.7** 12.59 ± 2.44 29.44 ± 3.07***
GP392 11.11 ± 4.85*** 17.03 ± 4.41*** 29.07 ± 3.39***
GP871 7.96 ± 1.67 13.7 ± 3.59 28.88 ± 3.42
GP873 8.51 ± 1.7** 15.18 ± 3.27** 27.96 ± 3.98***
GP681 9.07 ± 3.58* 12.03 ± 4.59 23.33 ± 3.23
GP551 5.55 ± 1.61 11.11 ± 2.28 23.33 ± 2.55***
GP526 9.07 ± 1.53*** 12.03 ± 1.67 18.7 ± 1.67
GP683 6.85 ± 2.13** 14.07 ± 4.36*** 22.22 ± 7.23***
GP884 6.48 ± 2.67 10.03 ± 2.8 17.03 ± 3.77
GP880 5.92 ± 3.14 8.7 ± 3.26 16.29 ± 3.59
GP684 5.37 ± 3.45** 10.37 ± 3.4 15.55 ± 3.96
GP877 3.51 ± 2.13 8.88 ± 4.57*** 15.37 ± 4.86*
Mean ± SD of the percentage of mortality. *P ≤ 0.05, **P ≤ 0.01 and ***P ≤ 0.001,
Kruskal-Wallis test
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The immersion technique previously described was used
[22], briefly, thirty adult mites were placed in microtubes
and 1 ml of protein from B. thuringiensis was added by
triplicate for 60 s. Mites were placed in agar petri dishes
containing water and filter paper, and sealed with Paraf-
ilm® to avoid dehydration. Mortality was determinated
and quantified microscopically, taking as dead mites
those lacking of reaction to stimulation with a brush,
with persistent immobility for 5 min [23, 24]. Bioassays
were repeated 4 times on different days.
Median lethal concentration (LC50) and median lethal
time (LT50)
We conducted a dose response curve performing 10 rep-
licates for each dose, and LC50 was the concentrations
inducing ≥50 % mortality. The LC50 was calculated
using Probit analysis via the Polo Plus 2003 statistical
program [25]. Mortality was quantified every 24 h, a lin-
ear regression analysis was performed, and data was
expressed as net mortality [18].
Histological analysis
The mites were fixed in 10 % formalin, processed ac-
cording to the paraffin embedded tissue technique, and
histological sections of 6 μm were obtained using an
MR2235 Leica microtome. Sections were stained with
hematoxylin-eosin, ten microscope fields were evaluated
in each section and photo-documented with an image
analyzer [26].
Protein profile
Five μg of concentrated spore-crystal in disruption buf-
fer were boiled for 10 min and centrifuged at
14,000 rpm for 5 min [27]. The supernatant was sepa-
rated by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) 10 % and the gel was stained with Coomassie
blue.
Results
Selection of strains, production of spore-crystal proteins
and in vitro bioassays
To analyze the acaricidal effect of total protein extracts
obtained from 13 strains of B. thuringiensis, we soaked
P. cuniculi mites in a solution with 1 mg/mL of total
protein for 60 s (Fig. 1). The dose of 1 mg/mL induced
mortality of several of the strains tested and it was tested
for different times after exposure to B. thuringiensis.
After 24, 48 and 72 h post-treatment, we found the max-
imum toxicity with strains GP532 and GP392 at 24 h
(11.48 ± 4.6 and 11.11) and 48 h (18.88 ± 7.92 and
17.037 ± 4.41) (Table 1). After 72 h, we observed the
highest toxicity with strains GP532, GP522, GP392, GP871
and GP873, inducing 34.62 % ± 5.95, 29.44 % ± 3.07,29 % ± 3.39, 28.8 % ± 3.42 and 27.9 % ± 3.98 respectively,
whereas in the control group we observed 16.4 % ± 2.72 of
mortality.
The strain that induced the highest toxicity was
GP532. Then, we tested GP532 strain increasing the
immersion time from 60 s to five minutes. With this
increase in the immersion time, we observed an increase
in toxicity from 34.64 % to 52.03 % after 72 h post-
treatment, while in the control group we did not observe
significant effect on mortality (from 16.46 % to 16.94 %).
This increase up to 52 % represents more than 300 %
(16.94 taken as 100 %), showing significant efficacy of
Fig. 2 Dose (a) and time-dependent (b) cytotoxicity induced by
immersion of mites in proteins of the strain GP532 for 5 min
(mean ± SD, *P≤ 0.05, **P≤ 0.01 and ***P≤ 0.001, Mann Whitney test)
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Alternatively, we tested the efficacy of the commercial
acaricide ivermectin, which produced 98 % of mortality
after 48 h post treatment (Table 2).
Median lethal concentration (LC50) and median lethal
time (LT50)
Subsequently, we evaluated different concentrations of
strain GP532 for 5 min of immersion and analyzed data
with a Probit analysis of survival to determine the LC50.
We found that LC50 is achieved with a concentration of
1.3 mg/mL (Fig. 2a).
To determine the toxicity of the strain GP532 at differ-
ent times, TL50 was evaluated every six hours post
immersion and analyzed by a linear regression analysis,
finding a TL50 of 68 h with a correlation of 0.94 after
immersion of mites during 5 min (Fig. 2b).
Histological analysis
Additionally, we analyzed the histoarchitecture of the
mites (Fig. 3), observing the presence of dilated inter-
cellular spaces in the peritrophic matrix of the intes-
tine after 1 min of treatment with 1 mg/ml of GP532.
Furthermore, we observed a greater amount of vacuole
shaped fat stores in the ventricular zone. It was also
observed that most of the treated mites had no intes-
tinal content (Fig. 3c) while mites in the control group
had no changes in the intestine and they had intestinal
content (Fig. 3a). The ventricular tissue in control
mites shown dispersed fat stores (Fig. 3b), while in
treated mites we observed presence of dilated intercel-
lular spaces in the basal membrane, detachment in the
membrane of the peritrophic matrix, and complete
emptying of the intestinal contents (Fig. 3c, arrows),
and in the ventricle we observed the presence of fat
pads (Fig. 3d, arrows). In the tissue treated with iver-
mectin, we observed absence of vacuolization and of
fatty deposits in both the intestine and in the ventricle
(Fig. 3e, f ).
Moreover, we observed morphological alterations in
columnar cells of the bowel in treated mites (Fig. 4b),
whereas in the tissue of control mites we did not ob-
serve changes in these cells (Fig. 4a). In ivermectin-
treated mites, we did not observe the changes inducedTable 2 Time-response toxicity induced by GP532 on mites
incubated for 5 min
Time post-treatment
Treatment 24 h 48 h 72 h
Control 6.20 ± 2.13 10.648 ± 3.54 16.94 ± 3.32
GP532 10.74 ± 3.28** 20.370 ± 3.79*** 52.03 ± 6.04***
Ivermectin 78.33 ± 11.27*** 98.88 ± 1.98*** 99.81 ± 0.78***
Mean ± SD of the percentage of mortality. **P ≤ 0.01 and ***P ≤ 0.001,
Kruskal-Wallis testby B. thuringiensis in the peritrophic matrix of intestine,
in the ventricular zone, or in columnar cells (Fig. 4c).
In the central nervous system of the mite, the syngan-
glion was observed histologically similar to the control
group (Fig. 5a) in both ivermectin treated mites (Fig. 5b)
and B. thuringiensis (Fig. 5c).
Electrophoretic profile of GP532 strain of B. thuringiensis
Subsequently, we analyzed the protein profile of strain
GP532, noting that the major bands in the protein pro-
file of strain GP532 have molecular weights ranging
from 25 to 135 kDa (Fig. 6).
Discussion
As it is well known, the insecticidal activity of B. thurin-
giensis is species specific. Here we isolated thirteen
strains of B. thuringiensis, most of them from corpses of
P. cuniculi, expecting to find a strain with acaricidal ac-
tivity. We evaluated their potential acaricidal effect
in vitro finding several strains causing mortality of the
mite. One of the strain reached 52.03 % of mortality
after 72 h post treatment, while the no treated mites had
16 % of mortality. This mortality was achieved with
1.3 mg mL-1, a dose relatively low comparative with
doses reported for thick affecting livestock, where they
reported that 1 mg/ml of B. thuringiensis kurstaki











Fig. 3 Photomicrograph of longitudinal sections in control (a, b), treated mites with the strain GP532 of B. thuringiensis (c, d) or with ivermectin
(e, f). LU: lumen of the intestine, MP: peritrophic matrix, EC: ectoperitrophic space, MB: basement membrane, CI: intestinal content, Va: vacuole,
VEM: medium ventricle, Ov: ovary. Arrows indicate alteration on the intestinal basement membrane or vacuole shaped fat deposits in ventricle,
H&E- X40
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A. persicus after five days. In addition, 2.5 mg mL-1 of B.
thuringiensis israelensis caused 100 % of mortality, and
5 mg mL-1 of B. thuringiensis thuringiensis caused
93.3 % of mortality on H. dromedarii [28–30]. These
doses are low comparative with those used to diminish
the 50 % of growth of synanthropic mites, where they
range between 25 and 38 mg g-1 [31], 30 times higher
than the CL50 reported in our study. Compared with the
studies mentioned above, we also had a shorter time for
effectiveness of B. thuringiensis against P. cuniculi. The
estimated LT50 in our study was 2.8 days, similar to data















   
 
Fig. 4 Representative image of the structure of the columnar cells in the m
GP532 of B. thuringiensis (b) or ivermectin c, and their respective images th
intercellular spaces of the columnar epithelium regarding the peritrophic mentomopathogenic fungus M. anisopliae on Psoroptes
spp, where the LT50 was 2.7 days at a concentration of
1x107 conidia mL-1, after 10 min of immersion [4]. Re-
garding the mortality reached, we obtained a dependable
LC50, but we were not able to reach a 100 % of mortal-
ity. However, it is possible to test this strain in future
studies, by applying several doses or longer times of
treatment in vivo, trying the purified protein with major
activity or using combined strains of B. thuringiensis as
possible strategies. In addition, as it was proposed by
Erban et al. [31], the combined application of B. thurin-
giensis with other compounds could increase the efficacy
of mite control. Therefore, GP532 strain could beite P. cuniculi without treatment (a) or after treatment with the strain
rough the relief filter (a1, b1, c1). Arrows indicate presence of dilated
atrix. Bar = 20 μm
Control GP-532 BT Ivermectin
Fig. 5 Photomicrograph of longitudinal sections in nervous system of control mites (a) or treated with the strain GP532 of B. thuringiensis (b) or
ivermectin (c). Syn: Synganglion
Fig. 6 Electrophoretic profile of GP532 strain of B. thuringiensis
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ture of B. thuringiensis with other acaricidal compounds.
For example, it has been proven that a combination of
chitinase and soybean trypsin protease inhibitor effect-
ively suppresses population growth in Acarus siro [33],
and many B. thuringiensis strains have chitinolytic activ-
ities [34] that could enhance the efficacy in mite control.
Another possible combination is with other natural
products as naphthoquinones, which could result in a
decrease of the induction of long-term resistance, with
short-term efficacy, and at a low cost [35].
Although in our study ivermectin showed a high ef-
fectiveness, several drawbacks of this drug have been
reported, which calls for the search for alternative treat-
ments. Ivermectin induced drug resistance has been
documented in in vitro assays with S. scabei at a concen-
tration as low as 100 μg g-1; as well, resistance has been
documented for some intestinal helminths in animals, in
arthropods and in humans [36–38]. Moreover, in cattle,
the dose of subcutaneous ivermectin is 200 μg kg-1,
while for rabbits the dose is 400 μg kg-1 to achieve
serum concentrations that allow a pharmacological ef-
fect against the parasite, and with this dose, it has been
proven that the drug remains at least after 348 h, repre-
senting a disadvantage in animals raised for human con-
sumption [39]. The main concern using ivermectin is
neurotoxicity, which in most mammalian species may
manifest as central nervous system depression, and con-
sequent ataxia, as it might be expected from promoters
of inhibitory GABAergic synapses [40]. In addition, sub-
cutaneous administration of ivermectin is painful for an-
imals, and although we have the option of topical
application, in rabbits it is unsuitable because of the nat-
ural behavior of licking each other in the ears as part of
their hygiene, that may affect the pharmacokinetics of
drugs, and prolonged treatment could cause intoxication
[41, 42]. Additionally, in male rabbits it was demonstrated
that repeated administration of ivermectin subcutaneously
causes a decrease in the weight of the sexual organs,
which can affect the animal production [43]. In future
studies, the combined use of B. thuringiensis and ivermec-
tin could also be analyzed, seeking a synergistic or additive
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tin and consequently its adverse effects.
Histologically, in mites treated with B. thuringiensis we
observed significant differences with regard to the nor-
mal tissue of untreated mites [44]. In the tissue of mites
treated with B. thuringiensis, we noticed an increase of
fat deposits adipocyte-like on the contour of the ven-
tricle. We found vacuolization in several cells, possibly
due to an accumulation of water and fat (hydropic
degeneration) caused by an inability of the cells to main-
tain ionic and fluid homeostasis due to glycogen degrad-
ation, that could explain the structural changes in the
tissue, like vacuolization and adipocytes to trap toxins
and other substances reported in ticks [45]. The mor-
phological alterations found in the intestine were not
caused by all the strains with acaricidal effect (not
shown), but whether these effects of agglomeration of
fat deposits were observed in the ventricular zone. The
damage on columnar cells and intestine were only ob-
served on mites treated with GP532 strain. Intestine
alterations on columnar cells were similar to those of an
histopathological study in intestinal tissue conducted
with Spodoptera frugiperda treated with aizawai-Xentari®
B. thuringiensis, and in other insects of the order of
Lepidoptera, Manduca sexta and Anticarsia gemmatalis
[46, 47] which suggests that the mechanism of action of
B. thuringiensis on the mite could be similar to that de-
scribed in Lepidoptera.
The electrophoretic profile of GP532 strain shows a
major band of about 135 kDa. It has been reported that
one of the proteins produced by B. thuringiensis sero-
variety kurstaki HD73 strain, is Cry1A that has an
approximate molecular weight of 133.3 kDa [48]. Also,
the action of B. thuringiensis on the mite of apicultural
importance, Varroa destructor, was reported, and the
active strain against this parasite has a 100 % identity with
B. thuringiensis serovariety kurstaki HD73 strain [18].
For mites, the mechanism of action of B. thuringiensis
is unknown. The presence of enzymes such as trypsin,
alkaline phosphatase and some aminopeptidases on
digestive physiology of the genus Psoroptes [49], suggest
that alterations in intestinal columnar cells observed in
P. cuniculi, may be due to activation of B. thuringiensis
protoxins like Cry1A, which in brush border membrane
vesicles of Lepidoptera induces alterations pore-like.
Cry1A acts through a specific receptor, the “Receptor
A”, an aminopeptidase-N with a molecular weight of
170 kDa that has been purified from brush border mem-
branes of intestinal epithelial cells of H. virescens [50]. In
other Lepidoptera, the molecular weight of receptors
reported are 120, 140 and 170 kDa [51]. In the present
study, we did not analyze the toxic action of specific pro-
teins isolated from B. thuringiensis on the mite P. cuniculi,
however, future studies will focus on these studies, as wellas sequencing of the toxic protein against the mite P. cuni-
culi to know the mechanism of action of B. thuringiensis
on mites.
In the in vitro tests, during the death of the mites in-
duced by B. thuringiensis we observed contractions prior
to death. This phenomenon has been reported in other
in vitro assays with ivermectin. In mammals, according
to the modeling of the mechanism of action, ivermectin
binds and it is transported by a membrane P-glycoprotein,
and activates glutamate-gated chloride channels interfer-
ing with nervous system and muscle function, enhancing
inhibitory neurotransmission [36, 52]. However, in our
study, we did not observe alterations in the synganglion,
which regulates nerve impulses in the mite; therefore, it is
possible to attribute the contractions to a degradation of
muscle glycogen, coupled with the instability caused by B.
thuringiensis homeostasis in the digestive system of the
mite.
Conclusions
Several B. thuringiensis strains isolated from P. cuniculi
tested in this work, had in vitro acaricidal effect on this
mite. The GP532 strain had the highest effect under our
experimental conditions, with a LC50 of 1.3 mg ml
-1, LT50
of 68 h, and producing histological alterations on the gut
of the mite.
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